Carobbi A et al. |
Effect of splenectomy in combination with FK 506 and 15-deoxyspergualin on cardiac xenograft survival. |
1991 |
Transplant. Proc. |
pmid:1703704
|
Berney T et al. |
Islet of Langerhans allogeneic transplantation at the University of Geneva in the steroid free era in islet after kidney and simultaneous islet-kidney transplantations. |
2004 |
Transplant. Proc. |
pmid:15194390
|
Gonzalez Molina M et al. |
Renal function in patients with cadaveric kidney transplants treated with tacrolimus or cyclosporine. |
2007 |
Transplant. Proc. |
pmid:17889126
|
Murase N et al. |
FK 506 prevents spontaneous diabetes in the BB rat. |
1991 |
Transplant. Proc. |
pmid:1703705
|
Undre NA and Schäfer A |
Factors affecting the pharmacokinetics of tacrolimus in the first year after renal transplantation. European Tacrolimus Multicentre Renal Study Group. |
1998 |
Transplant. Proc. |
pmid:9636512
|
Lauzurica R et al. |
Subclinical inflammation in renal transplant recipients: impact of cyclosporine microemulsion versus tacrolimus. |
2007 |
Transplant. Proc. |
pmid:17889127
|
Manzanares C et al. |
Influence of hepatitis C virus infection on FK 506 blood levels in renal transplant patients. |
1998 |
Transplant. Proc. |
pmid:9636513
|
Masutani K et al. |
Protocol biopsy findings in living donor kidney transplant patients treated with once-daily or twice-daily tacrolimus formulation. |
2014 |
Transplant. Proc. |
pmid:24655972
|
Pérez-Flores I et al. |
Intracellular ATP levels in CD4+ lymphocytes are a risk marker of rejection and infection in renal graft recipients. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715845
|
Spinelli GA et al. |
Lipid profile changes during the first year after kidney transplantation: risk factors and influence of the immunosuppressive drug regimen. |
2011 |
Transplant. Proc. |
pmid:22172836
|
Latorre A et al. |
Clinical management of renal transplant patients with hepatitis C virus infection treated with cyclosporine or tacrolimus. |
2002 |
Transplant. Proc. |
pmid:11959186
|
Urbizu JM et al. |
Immunosuppression using tacrolimus/mycophenolate versus neoral/mycophenolate following kidney transplantation: a single-center experience. |
2002 |
Transplant. Proc. |
pmid:11959197
|
Soda M et al. |
Association Between Tacrolimus Pharmacokinetics and Cytochrome P450 3A5 and Multidrug Resistance Protein 1 Exon 21 Polymorphisms. |
|
Transplant. Proc. |
pmid:28736028
|
Mac Guad R et al. |
Effects of CYP3A5 Genetic Polymorphism on the Pharmacokinetics of Tacrolimus in Renal Transplant Recipients. |
|
Transplant. Proc. |
pmid:26915847
|
Zeevi A et al. |
Comparative in vitro studies on the immunosuppressive effects of purine and pyrimidine synthesis inhibitors. |
1993 |
Transplant. Proc. |
pmid:7679843
|
Ali Shah I et al. |
Effects of FK 506 on human hepatic microsomal cytochrome P-450-dependent drug metabolism in vitro. |
1991 |
Transplant. Proc. |
pmid:1721276
|
Ohara K et al. |
Toxicologic evaluation of FK 506. |
1990 |
Transplant. Proc. |
pmid:1689910
|
Wakizaka Y et al. |
Xenotransplantation of hamster liver into Gunn rats reserves congenital hyperbilirubinemia. |
1996 |
Transplant. Proc. |
pmid:8623372
|
Rudich SM et al. |
Immunosuppression using tacrolimus, mycophenolate, and prednisone following orthotopic liver transplantation: a single-center experience. |
1998 |
Transplant. Proc. |
pmid:9636574
|
Chueh SC et al. |
Drug fever caused by mycophenolate mofetil in a renal transplant recipient--a case report. |
2000 |
Transplant. Proc. |
pmid:11120003
|
Ueno T et al. |
Renal dysfunction following adult intestinal transplant under tacrolimus-based immunosuppression. |
2006 Jul-Aug |
Transplant. Proc. |
pmid:16908274
|
Oltean M et al. |
Transplantation of preconditioned intestinal grafts is associated with lower inflammatory activation and remote organ injury in rats. |
2006 Jul-Aug |
Transplant. Proc. |
pmid:16908278
|
Burkhalter F et al. |
High incidence of rejection episodes and poor tolerance of sirolimus in a protocol with early steroid withdrawal and calcineurin inhibitor-free maintenance therapy in renal transplantation: experiences of a randomized prospective single-center study. |
2012 |
Transplant. Proc. |
pmid:23195006
|
Bora F et al. |
Drug interaction between tacrolimus and ertapenem in renal transplantation recipients. |
2012 |
Transplant. Proc. |
pmid:23195020
|
Charco R et al. |
Steroids and living liver donation increase tacrolimus blood levels in living donor liver transplantation. |
2005 |
Transplant. Proc. |
pmid:16386588
|
Crespo-Leiro MG |
Calcineurin inhibitors in heart transplantation. |
2005 |
Transplant. Proc. |
pmid:16386614
|
Jain AB et al. |
One thousand consecutive primary orthotopic liver transplants under FK 506: survival and adverse events. |
1995 |
Transplant. Proc. |
pmid:7533353
|
Rucay P et al. |
FK 506 as treatment of late acute rejection in liver transplant patients. |
1995 |
Transplant. Proc. |
pmid:7533354
|
Morris RE et al. |
A study of the contrasting effects of cyclosporine, FK 506, and rapamycin on the suppression of allograft rejection. |
1990 |
Transplant. Proc. |
pmid:1697111
|
Katz HR et al. |
Mast cell biochemical and functional heterogeneity. |
1991 |
Transplant. Proc. |
pmid:1721308
|
Oppenheimer F |
Steroid withdrawal in renal transplant recipients. |
2000 |
Transplant. Proc. |
pmid:10686314
|
Woo J et al. |
Flow cytometric analysis of lymphocyte populations and activation antigen expression in blood and lymphoid tissues of FK 506-treated rats. |
1990 |
Transplant. Proc. |
pmid:1697112
|
Tamura A et al. |
Combination effect of tacrolimus and FTY720 in liver transplantation in rats. |
1999 |
Transplant. Proc. |
pmid:10578290
|
Florman S et al. |
Conversion of stable liver transplant recipients from a twice-daily Prograf-based regimen to a once-daily modified release tacrolimus-based regimen. |
2005 |
Transplant. Proc. |
pmid:15848672
|
Niederstadt C et al. |
Effect of FK506 on magnesium homeostasis after renal transplantation. |
1997 |
Transplant. Proc. |
pmid:9365709
|
Chen J et al. |
Observation of efficacy and safety of converting the calcineurin inhibitor to sirolimus in renal transplant recipients with chronic allograft nephropathy. |
2008 |
Transplant. Proc. |
pmid:18589119
|
Chen JW et al. |
Ten-year results of a randomised prospective study of FK506 versus cyclosporine in management of primary orthotopic liver transplantation. |
2002 |
Transplant. Proc. |
pmid:12176460
|
Fukuzaki T et al. |
Induction of unresponsiveness to islet allografts with donor spleen cell inoculation followed by a single injection of FK 506. |
1995 |
Transplant. Proc. |
pmid:7533407
|
Marcén R et al. |
Conversion from cyclosporine microemulsion to tacrolimus in stable kidney transplant patients with hypercholesterolemia is related to an improvement in cardiovascular risk profile: a prospective study. |
2006 |
Transplant. Proc. |
pmid:17097957
|
Rucay P et al. |
FK 506 rescue therapy for refractory acute rejection in five liver recipients. |
1991 |
Transplant. Proc. |
pmid:1721340
|
Mortensen DM et al. |
Calcineurin activity in tacrolimus-treated renal transplant patients early after and 5 years after transplantation. |
2006 |
Transplant. Proc. |
pmid:17098028
|
Lee KK et al. |
Comparison of short-term immunosuppressive therapy with cyclosporine and FK 506 in small-bowel transplantation. |
1990 |
Transplant. Proc. |
pmid:1702239
|
Borrows R et al. |
Steroid sparing in renal transplantation with tacrolimus and mycophenolate mofetil: three-year results. |
2005 |
Transplant. Proc. |
pmid:15919468
|
Gozdowska J et al. |
Safety and tolerance of sodium mycophenolate in patients after renal transplantation--an observational study. |
2009 |
Transplant. Proc. |
pmid:19857665
|
Loucaidou M et al. |
Late steroid withdrawal for renal transplant recipients on tacrolimus and MMF is safe. |
2005 |
Transplant. Proc. |
pmid:15919469
|
Malyszko J et al. |
A possible role of hepcidin in the pathogenesis of anemia among kidney allograft recipients. |
2009 |
Transplant. Proc. |
pmid:19857675
|
Tsuchida Y et al. |
Vascularized bone marrow allotransplantation in rats prolongs a simultaneous skin allograft. |
1997 |
Transplant. Proc. |
pmid:9142252
|
Costa A et al. |
Small bowel myoelectrical activity after transplantation in pigs: motility versus ACR score. |
1997 |
Transplant. Proc. |
pmid:9142281
|
Kitamura M et al. |
Clinical experience of FK 506 for renal allograft transplantation. |
1994 |
Transplant. Proc. |
pmid:7520611
|
Hung CM et al. |
Tacrolimus to rescue refractory hepatic allograft rejection: a collaborative study in Taiwan. |
1998 |
Transplant. Proc. |
pmid:9838572
|
Fung JJ et al. |
Adverse effects associated with the use of FK 506. |
1991 |
Transplant. Proc. |
pmid:1721372
|
Omar G et al. |
FK 506 inhibition of cyclosporine metabolism by human liver microsomes. |
1991 |
Transplant. Proc. |
pmid:1703356
|
Miller J |
Tacrolimus and mycophenolate mofetil in renal transplant recipients: one year results of a multicenter, randomized dose ranging trial. FK506/MMF Dose-Ranging Kidney Transplant Study Group. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083106
|
Boots JM et al. |
Pretransplant pharmacokinetics: does it predict the dose of tacrolimus after renal transplantation? |
2002 |
Transplant. Proc. |
pmid:12493409
|
Peraira JR et al. |
High incidence of severe infections in heart transplant recipients receiving tacrolimus. |
2003 |
Transplant. Proc. |
pmid:12962875
|
Busuttil RW and Holt CD |
Tacrolimus (FK506) is superior to cyclosporine in liver transplantation. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123119
|
Cho WH et al. |
Basiliximab does not reduce the early rejection incidence in high-risk kidney recipients under tacrolimus-based immunosuppression. |
2008 |
Transplant. Proc. |
pmid:18790201
|
Namieno T and Uchino J |
Comparative study of the effects of cyclosporine and FK 506 on rat hepatocytes cocultured with nonparenchymal liver cells. |
1996 |
Transplant. Proc. |
pmid:8908147
|
Okamoto M et al. |
Tacrolimus-based immunosuppression in renal transplantation: 78 experiences in a single Japanese center. |
2002 |
Transplant. Proc. |
pmid:12176527
|
Kim JD et al. |
Single-Center Experience of ABO-Incompatible Living-Donor Liver Transplantation With a New Simplified Intravenous Immunoglobulin Protocol: A Propensity Score-Matching Analysis. |
2016 |
Transplant. Proc. |
pmid:27320573
|
Aono T et al. |
Minimal threshold of FK 506 for enhancing liver regeneration in thymectomized rats. |
1995 |
Transplant. Proc. |
pmid:7536981
|
Mor E et al. |
Homocysteine levels among transplant recipients: effect of immunosuppressive protocols. |
2001 |
Transplant. Proc. |
pmid:11543802
|
Morrisett JD et al. |
Effect of FK 506 and cyclosporine on plasma cholesterol levels in rabbits. |
1991 |
Transplant. Proc. |
pmid:1721402
|
Kobayashi N et al. |
Abdominal organ cluster transplantation in pigs receiving FK 506. |
1992 |
Transplant. Proc. |
pmid:1379754
|
Jordan ML et al. |
Tacrolimus rescue therapy for renal transplant rejection. |
1996 |
Transplant. Proc. |
pmid:8769174
|
Kokado Y et al. |
Low-dose tacrolimus (FK 506)-based immunosuppressive protocol in living donor renal transplantation. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083515
|
Weinbroum AA et al. |
Lack of cumulative effect of tacrolimus and low flow on a rat isolated liver. |
2001 |
Transplant. Proc. |
pmid:11543812
|
Jacobs TW et al. |
The effect of FK 506, cyclosporine A, and cyclosporine G on serum 1,25-dihydroxyvitamin D levels. |
1991 |
Transplant. Proc. |
pmid:1721403
|
Yoshimura R et al. |
A comparative study of cyclosporine vs FK 506: role of kidney microsomal cytochrome P-450. |
1992 |
Transplant. Proc. |
pmid:1379755
|
Baruch Y et al. |
Anasarca and hypertrophic cardiomyopathy in a liver transplant patient on FK506: relieved after a switch to Neoral. |
1996 |
Transplant. Proc. |
pmid:8769215
|
Zuckermann A et al. |
Benefit of mycophenolate mofetil in patients with cyclosporine A-induced nephropathy after lung transplantation. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083518
|
Kuroki H et al. |
Experimental studies of vascularized allogeneic limb transplantation in the rat using a new immunosuppressive agent, FK-506: morphological and immunological analysis. |
1989 |
Transplant. Proc. |
pmid:2468255
|
Arai K et al. |
Prolonged limb allograft survival with short-term treatment with FK-506 in rats. |
1989 |
Transplant. Proc. |
pmid:2468256
|
Matsumiya G et al. |
Serum interleukin-6 level after cardiac xenotransplantation in primates. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123586
|
Ohdan H et al. |
Prolongation of hamster-to-rat liver xenograft survival by donor bone marrow augmentation. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123589
|
Langrehr JM et al. |
Quadruple versus dual tacrolimus-based induction after liver transplantation: a prospective, randomized trial. |
2001 |
Transplant. Proc. |
pmid:11377549
|
Uber PA et al. |
Steroid weaning in heart transplantation is associated with decreased B-type natriuretic peptide: surrogate evidence for cardiac adaptation. |
2002 |
Transplant. Proc. |
pmid:12176598
|
Wu M et al. |
Cyclosporine and tacrolimus alter renin-angiotesin system in mouse medullary-thick ascending limb cultured cells. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267198
|
Wada H et al. |
An attempt to induce tolerance to skin grafts in congenic mice with FK 506. |
1991 |
Transplant. Proc. |
pmid:1721435
|
Ghio L et al. |
Conversion from tacrolimus to cyclosporine for a non-dose-dependent tacrolimus-induced toxicity, a pediatric kidney transplant recipient case report. |
2004 |
Transplant. Proc. |
pmid:15251325
|
Calne R et al. |
Observations about FK-506 in primates. |
1987 |
Transplant. Proc. |
pmid:2445078
|
Grabczewska Z et al. |
Neither cyclosporine nor tacrolimus deteriorate endothelial function in renal transplant recipients assessed with reactive hyperernia index. |
2013 |
Transplant. Proc. |
pmid:23726621
|
Halloran PF et al. |
Calcineurin and the biological effect of cyclosporine and tacrolimus. |
1998 |
Transplant. Proc. |
pmid:9723430
|
Renner FC et al. |
The risk of polyomavirus-associated graft nephropathy is increased by a combined suppression of CD8 and CD4 cell-dependent immune effects. |
2013 |
Transplant. Proc. |
pmid:23726630
|
Walgenbach KJ et al. |
Upregulation of basic fibroblast growth factor during chronic rejection of rat intestinal allografts and its downregulation by FK 506. |
1998 |
Transplant. Proc. |
pmid:9745501
|
Pankewycz O et al. |
Conversion to low-dose tacrolimus or rapamycin 3 months after kidney transplantation: a prospective, protocol biopsy-guided study. |
2011 |
Transplant. Proc. |
pmid:21440749
|
Laftavi MR et al. |
The role of antibiotic prophylaxis in the new era of immunosuppression. |
2011 |
Transplant. Proc. |
pmid:21440753
|
Jordan ML et al. |
Steroid withdrawal for pancreas transplants under tacrolimus immunosuppression. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267456
|
Konno O et al. |
Early Outcomes of Living-Donor Kidney Transplantation With Immunosuppression Therapy Induction With Tacrolimus Extended-Release: A Comparison With Cyclosporine. |
2018 |
Transplant. Proc. |
pmid:30316378
|
Li S et al. |
Intrathymic inoculation of donor bone marrow at the time of transplantation plus a short course of tacrolimus induce long-term acceptance to rat lung allografts. |
1998 |
Transplant. Proc. |
pmid:9636431
|
Pinho-Apezzato ML et al. |
Multiple clinical presentations of lymphoproliferative disorders in pediatric liver transplant recipients: a single-center experience. |
2010 |
Transplant. Proc. |
pmid:20620519
|
Suarez Benjumea A et al. |
Hepatitis C Virus in Kidney Transplant Recipients: A Problem on the Path to Eradication. |
2016 |
Transplant. Proc. |
pmid:27932111
|
Rodriguez Cubillo B et al. |
Risk Factors of Recurrence of Diabetic Nephropathy in Renal Transplants. |
2016 |
Transplant. Proc. |
pmid:27932117
|
Rathi M et al. |
Conversion from tacrolimus to cyclosporine in patients with new-onset diabetes after renal transplant: an open-label randomized prospective pilot study. |
2015 |
Transplant. Proc. |
pmid:26036543
|
Mohsin N et al. |
Pharmacokinetics of mycophenolate mofetil in Omani patients on cyclosporine or tacrolimus. |
2015 |
Transplant. Proc. |
pmid:26036534
|
Hariharan S et al. |
Conversion from cyclosporine to tacrolimus after pancreas transplantation. |
1995 |
Transplant. Proc. |
pmid:8539799
|
Henley SE et al. |
Lipids following pancreas transplantation in recipients receiving FK 506. |
1995 |
Transplant. Proc. |
pmid:8539809
|
Hartwig T et al. |
Low-dose sirolimus and tacrolimus in kidney transplantation: first results of a single-center experience. |
2001 Nov-Dec |
Transplant. Proc. |
pmid:11750383
|
Stratta RJ et al. |
Preliminary experience with FK 506 in pancreas transplant recipients. |
1995 |
Transplant. Proc. |
pmid:8539823
|
Pridöhl O et al. |
Low-dose immunosuppression with FK 506 and sirolimus after liver transplantation: 1-year results. |
2001 Nov-Dec |
Transplant. Proc. |
pmid:11750384
|